Actualités Abraxis Bioscience (MM) - ABBI | Actions NASDAQ

Votre Hub pour des idées et discussions en direct en temps réel

Deloitte Names Abraxis BioScience Inc. Fastest Growing Technology Company in Los Angeles Area

Los Angeles Area Companies Comprise Five Percent of Deloitte's 2008 Technology Fast 500 LOS ANGELES, Nov. 12 /PRNewswire/ -- Abraxis BioScience...

Deloitte Unveils 2008 Technology Fast 500 Ranking

Apple Makes First-Ever Appearance on List NEW YORK, Nov. 12 /PRNewswire-FirstCall/ -- Hughes Communications Inc. (NASDAQ:HUGH) is the fastest...

Abraxis Bioscience, Inc. (Other) (S-8 POS)

As filed with the Securities and Exchange Commission on November 13, 2007 Registration No. 333-103894 UNITED STATES...

Abraxis Bioscience, Inc. (Other) (S-8 POS)

As filed with the Securities and Exchange Commission on November 13, 2007 Registration No. 333-141034 UNITED STATES SECURITIES AND...

Abraxis Bioscience, Inc. (Other) (S-8 POS)

As filed with the Securities and Exchange Commission on November 13, 2007 Registration No. 333-84280 UNITED STATES...

Abraxis Bioscience, Inc. (Other) (S-8 POS)

As filed with the Securities and Exchange Commission on November 13, 2007 Registration No. 333-75606 UNITED STATES...

Abraxis Bioscience, Inc. (Other) (POSASR)

As filed with the Securities and Exchange Commission on November 13, 2007 Registration No. 333-135383 UNITED STATES...

Abraxis Bioscience, Inc. (Other) (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE...

Abraxis Bioscience, Inc. - Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE...

Abraxis Bioscience, Inc. - Prospectus filed pursuant to Rule 424(b)(7) (424B7)

Table of Contents Filed Pursuant to Rule 424(b)(7) Registration No. 333-135383 PROSPECTUS SUPPLEMENT (To...

Abraxis Bioscience, Inc. - Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Abraxis Bioscience, Inc. - Amended Statement of Changes in Beneficial Ownership (4/A)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

APP Receives Expedited Approval for the First and Only Generic Cefotetan Disodium for Injection

Abraxis Pharmaceutical Products (APP), the hospital-based business of Abraxis BioScience, Inc. (NASDAQ:ABBI), today announced the...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Abraxis Bioscience (MM) (ABBI)

Votre Hub pour des idées et discussions en direct en temps réel

ABBI Actualités

Deloitte Names Abraxis BioScience Inc. Fastest Growing Technology Company in Los Angeles Area

Deloitte Unveils 2008 Technology Fast 500 Ranking

Abraxis Bioscience, Inc. (Other) (S-8 POS)

Abraxis Bioscience, Inc. (Other) (S-8 POS)

Abraxis Bioscience, Inc. (Other) (S-8 POS)

Abraxis Bioscience, Inc. (Other) (S-8 POS)

Abraxis Bioscience, Inc. (Other) (POSASR)

Abraxis Bioscience, Inc. (Other) (8-K)

Abraxis Bioscience, Inc. - Current report filing (8-K)

Abraxis Bioscience, Inc. - Prospectus filed pursuant to Rule 424(b)(7) (424B7)

Abraxis Bioscience, Inc. - Statement of Changes in Beneficial Ownership (4)

Abraxis Bioscience, Inc. - Amended Statement of Changes in Beneficial Ownership (4/A)

APP Receives Expedited Approval for the First and Only Generic Cefotetan Disodium for Injection

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Abraxis Bioscience (MM) (ABBI) Actualités

Abraxis Bioscience (MM) (ABBI)

Votre Hub pour des idées et discussions en direct en temps réel

ABBI Actualités

Deloitte Names Abraxis BioScience Inc. Fastest Growing Technology Company in Los Angeles Area

Deloitte Unveils 2008 Technology Fast 500 Ranking

Abraxis Bioscience, Inc. (Other) (S-8 POS)

Abraxis Bioscience, Inc. (Other) (S-8 POS)

Abraxis Bioscience, Inc. (Other) (S-8 POS)

Abraxis Bioscience, Inc. (Other) (S-8 POS)

Abraxis Bioscience, Inc. (Other) (POSASR)

Abraxis Bioscience, Inc. (Other) (8-K)

Abraxis Bioscience, Inc. - Current report filing (8-K)

Abraxis Bioscience, Inc. - Prospectus filed pursuant to Rule 424(b)(7) (424B7)

Abraxis Bioscience, Inc. - Statement of Changes in Beneficial Ownership (4)

Abraxis Bioscience, Inc. - Amended Statement of Changes in Beneficial Ownership (4/A)

APP Receives Expedited Approval for the First and Only Generic Cefotetan Disodium for Injection

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités